NCT00594945

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

A Phase 2a, Open-label,Proof -Of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Jazz Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.

Conditions

• Epilepsy

Interventions

Type	Name	Description
DRUG	Clonazepam	1 Dose

Timeline

• Start date: 2007-12-01
• Primary completion: 2008-12-01
• Completion: 2009-06-01
• First posted: 2008-01-16
• Last updated: 2014-07-01
• Results posted: 2014-07-01

Locations

6 sites across 2 countries: United States, Finland